Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
Condition(s):Transthyretin Amyloidosis; Amyloidosis, Leptomeningeal, Transthyretin-RelatedLast Updated:June 14, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Transthyretin Amyloidosis; Amyloidosis, Leptomeningeal, Transthyretin-RelatedLast Updated:June 14, 2019Completed
Condition(s):Obsessive-Compulsive Disorder; OCDLast Updated:July 13, 2023Recruiting
Condition(s):Alcohol Abuse; Impulsive BehaviorLast Updated:September 21, 2020Completed
Condition(s):NeuroblastomaLast Updated:September 28, 2023Terminated
Condition(s):Obsessive-Compulsive DisorderLast Updated:April 7, 2022Completed
Condition(s):Pathological GamblingLast Updated:February 23, 2023Completed
Condition(s):Nicotine DependenceLast Updated:September 12, 2018Completed
Condition(s):Brain Injuries, Traumatic; Neurocognitive Disorders; Brain InjuriesLast Updated:January 19, 2017Unknown status
Condition(s):Healthy VolunteersLast Updated:January 31, 2019Completed
Condition(s):HealthyLast Updated:September 12, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.